Target intelligence / Profile preview

Submucosal gland secretion machinery

Molecular classification
Ion channel, Transporter, G protein-coupled receptor, Enzyme, Secretory protein, Other
01

Overview

The submucosal gland secretion machinery is a complex physiological system located primarily in the cartilaginous airways and parts of the gastrointestinal tract, responsible for producing the majority of mucus and antimicrobial fluids (Wine, J. J., 2007, J. Clin. Invest.). This machinery integrates the activity of various ion channels, such as the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Anoctamin-1 (TMEM16A), with transporters like the Na-K-2Cl cotransporter (NKCC1) to drive the osmotic movement of water into the gland lumen (Widdicombe, J. H., 2002, J. Anat.). These processes are regulated by autonomic signaling through M3 muscarinic and beta-2 adrenergic receptors, which trigger the exocytosis of MUC5B mucins and defensive proteins like lysozyme and lactoferrin (Fahy, J. V., & Dickey, B. F., 2010, N. Engl. J. Med.). In diseases like cystic fibrosis, the failure of the CFTR component leads to the secretion of hyperviscous mucus that impairs mucociliary clearance and promotes infection (Boucher, R. C., 2007, J. Biol. Chem.). Conversely, in COPD and asthma, hypertrophy of the glands and overactivity of the machinery result in mucus hypersecretion and airway obstruction. Pharmacological intervention typically targets individual components of this machinery, such as using CFTR modulators to restore hydration or muscarinic antagonists to reduce secretory volume.

Other names
Airway submucosal glandsMucus secretory apparatusBronchial gland secretion systemSMG secretory machinery
02

Mechanism of action

Activation or inhibition of specific components within the machinery, such as ion channels (CFTR) or G protein-coupled receptors (M3 muscarinic), to modulate the volume and rheology of secreted mucus.

03

Biological functions

Mucus secretionFluid transportInnate immunityMucociliary clearanceAirway hydrationOther
04

Disease associations

Cystic FibrosisChronic Obstructive Pulmonary DiseaseAsthmaChronic BronchitisOther
05

Safety considerations

Mucus pluggingXerostomiaSystemic anticholinergic effectsElectrolyte imbalanceAirway dehydration
06

Interacting drugs

Ivacaftor

7 more in the full profile.

07

Biomarkers

MUC5BLysozymeLactoferrinSputum volumeSputum viscosityNasal potential difference

Beyond the preview

Go deeper on Submucosal gland secretion machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Submucosal gland secretion machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call